27023226|t|Astragaloside IV, a Natural PPARgamma Agonist, Reduces Abeta Production in Alzheimer's Disease Through Inhibition of BACE1.
27023226|a|A number of epidemiological studies have established a link between Alzheimer's disease (AD) and diabetes mellitus (DM). So, nuclear receptor peroxisome proliferator-activated receptor gamma (PPARgamma) plays an important role in the treatment of AD. However, current PPARgamma-targeting drugs such as thiazolidinediones (TZDs) are associated with undesirable side effects. We identified herbal extract with a small molecular, astragaloside IV (AS-IV), as a selective PPARgamma natural agonist in nervous cells by developing a PPAR-PPRE pathway regulatory system. Cultured SH-SY5Y cells transfected with pEGFP-N1-BACE1 were treated with AS-IV for 24 h or AS-IV plus the PPAR-gamma antagonist GW9662 in vitro. APP/PS1 mice were intragastrically treated with AS-IV or AS-IV plus the GW9662 every 48 h for 3 months. Immunofluorescence, western blotting, and real-time PCR were used to examine the expression of PPARgamma and BACE1. Immunohistochemical staining was performed to analyze the distribution of Abeta plaques in the APP/PS1 mouse brain. The levels of Abeta were determined using ELISA kits. AS-IV was shown to be a PPARgamma agonist by establishing a high-throughput screening model for PPARgamma agonists. The results showed that AS-IV treatment increased activity of PPARgamma and inhibited BACE1 in vitro. As a result, Abeta levels decreased significantly. GW9662, which is a PPARgamma antagonist, significantly blocked the beneficial role of AS-IV. In vivo, AS-IV treatment increased PPARgamma and BACE1 expression and reduced neuritic plaque formation and Abeta levels in the brains of APP/PS1 mice. These effects of AS-IV could be effectively inhibited by GW9662. These results indicate that AS-IV may be a natural PPARgamma agonist that suppressed activity of BACE1 and ultimately attenuates generation of Abeta. Therefore, AS-IV may be a promising agent for modulating Abeta-related pathology in AD.
27023226	0	16	Astragaloside IV	Chemical	MESH:C052064
27023226	28	37	PPARgamma	Gene	19016
27023226	55	60	Abeta	Gene	11820
27023226	75	94	Alzheimer's Disease	Disease	MESH:D000544
27023226	117	122	BACE1	Gene	23621
27023226	192	211	Alzheimer's disease	Disease	MESH:D000544
27023226	213	215	AD	Disease	MESH:D000544
27023226	221	238	diabetes mellitus	Disease	MESH:D003920
27023226	240	242	DM	Disease	MESH:D003920
27023226	266	314	peroxisome proliferator-activated receptor gamma	Gene	5468
27023226	316	325	PPARgamma	Gene	19016
27023226	371	373	AD	Disease	MESH:D000544
27023226	392	401	PPARgamma	Gene	19016
27023226	426	444	thiazolidinediones	Chemical	MESH:D045162
27023226	446	450	TZDs	Chemical	MESH:D045162
27023226	512	526	herbal extract	Chemical	-
27023226	551	567	astragaloside IV	Chemical	MESH:C052064
27023226	569	574	AS-IV	Chemical	MESH:C052064
27023226	592	601	PPARgamma	Gene	19016
27023226	651	655	PPAR	Gene	19013
27023226	697	704	SH-SY5Y	CellLine	CVCL:0019
27023226	737	742	BACE1	Gene	23621
27023226	761	766	AS-IV	Chemical	MESH:C052064
27023226	779	784	AS-IV	Chemical	MESH:C052064
27023226	794	804	PPAR-gamma	Gene	19016
27023226	816	822	GW9662	Chemical	MESH:C457499
27023226	837	840	PS1	Gene	19164
27023226	841	845	mice	Species	10090
27023226	881	886	AS-IV	Chemical	MESH:C052064
27023226	890	895	AS-IV	Chemical	MESH:C052064
27023226	905	911	GW9662	Chemical	MESH:C457499
27023226	1032	1041	PPARgamma	Gene	5468
27023226	1046	1051	BACE1	Gene	23821
27023226	1127	1132	Abeta	Gene	11820
27023226	1152	1155	PS1	Gene	19164
27023226	1156	1161	mouse	Species	10090
27023226	1183	1188	Abeta	Gene	11820
27023226	1223	1228	AS-IV	Chemical	MESH:C052064
27023226	1247	1256	PPARgamma	Gene	19016
27023226	1319	1328	PPARgamma	Gene	19016
27023226	1363	1368	AS-IV	Chemical	MESH:C052064
27023226	1401	1410	PPARgamma	Gene	5468
27023226	1425	1430	BACE1	Gene	23621
27023226	1454	1459	Abeta	Gene	11820
27023226	1492	1498	GW9662	Chemical	MESH:C457499
27023226	1511	1520	PPARgamma	Gene	19016
27023226	1578	1583	AS-IV	Chemical	MESH:C052064
27023226	1594	1599	AS-IV	Chemical	MESH:C052064
27023226	1620	1629	PPARgamma	Gene	5468
27023226	1634	1639	BACE1	Gene	23821
27023226	1663	1678	neuritic plaque	Disease	MESH:D058225
27023226	1693	1698	Abeta	Gene	11820
27023226	1727	1730	PS1	Gene	19164
27023226	1731	1735	mice	Species	10090
27023226	1754	1759	AS-IV	Chemical	MESH:C052064
27023226	1794	1800	GW9662	Chemical	MESH:C457499
27023226	1830	1835	AS-IV	Chemical	MESH:C052064
27023226	1853	1862	PPARgamma	Gene	19016
27023226	1899	1904	BACE1	Gene	23821
27023226	1945	1950	Abeta	Gene	11820
27023226	1963	1968	AS-IV	Chemical	MESH:C052064
27023226	2009	2014	Abeta	Gene	11820
27023226	2036	2038	AD	Disease	MESH:D000544
27023226	Association	MESH:D000544	5468
27023226	Positive_Correlation	MESH:C052064	5468
27023226	Negative_Correlation	MESH:C052064	MESH:D058225
27023226	Positive_Correlation	MESH:C052064	19016
27023226	Positive_Correlation	MESH:C052064	23821
27023226	Association	MESH:D000544	23621
27023226	Negative_Correlation	MESH:C052064	11820
27023226	Association	MESH:D000544	19016
27023226	Negative_Correlation	MESH:C052064	23621
27023226	Negative_Correlation	MESH:C052064	MESH:D000544
27023226	Negative_Correlation	MESH:C457499	19016
27023226	Association	MESH:D045162	19016
27023226	Association	MESH:D000544	11820
27023226	Negative_Correlation	MESH:C052064	MESH:C457499
27023226	Association	11820	23621

